GALANTAMINE UK

Inhouse Pharmacy (UK) Treatment for Alzheimer`s disease: Reminyl - galantamineReminyl is the brand name for the drug galantamine hydrobromide. It is licensed for the treatment of mild to moderately severe Alzheimer's disease.The effect of the drug will vary for different people. Some will not notice an effect at all. Others may find that their condition improves, or that they stay the same when they would have expected to get gradually less able because of the progression of Alzheimer's disease.Reminyl has been tested in large-scale trials on about 3,000 people. These studies were placebo-controlled and double-blind for six months, which means that some people received Reminyl and others received a placebo (dummy) tablet. None of the patients knew whether they were getting the drug or the placebo. At the end of the six months, all patients who chose to could receive Reminyl for a further six-month study, where no-one was on placebo. The drug companies also have information from earlier studies about how people with Alzheimer's disease score on these tests when taking placebo treatment over a period of a year, and they used this information to make some of the comparisons.